KRAS and neoplasm: HCT116, a colon cancer line that harbors a KRASG13D mutation and IPC298, a cutaneous melanoma cell line bearing an NRASQ61L mutation, were chosen for this study since KRAS in colorectal cancer and NRAS in melanoma is the most frequently mutated RAS gene in these tumor types.